Penalties for crime of altering controlled substances with fentanyl provided.
Summary
HF 1446 creates a new felony offense for knowingly adulterating or altering a controlled substance or drug with fentanyl, or replacing a controlled substance in a package or receptacle with fentanyl. The bill also covers swapping one package or receptacle containing a controlled substance for another containing fentanyl, making it a crime to introduce fentanyl into another drug supply through substitution or tampering.
The bill includes an exemption for manufacturers, practitioners, pharmacists, pharmacy owners, nurses, and other persons acting in a professional capacity. It defines the covered terms by reference to existing Minnesota controlled-substance and drug definitions and states that the new law takes effect August 1, 2025, applying to offenses committed on or after that date.
Impact
The bill adds a new section to Minnesota Statutes chapter 609, expanding the state’s criminal code to specifically address fentanyl adulteration and substitution of controlled substances. It would give prosecutors a distinct felony charge for conduct involving fentanyl-laced or fentanyl-swapped drugs, supplementing existing controlled-substance laws and potentially increasing criminal exposure for people who tamper with drug supplies. The measure does not change professional medical or pharmacy handling of drugs when done in the course of lawful practice.
Sentiment
Based on the bill text and the absence of recorded committee testimony or votes, the measure appears to be a straightforward public-safety response to fentanyl-related drug contamination. The caption and structure suggest a punitive approach aimed at deterring dangerous drug tampering, with no visible opposition or amendment history in the provided materials. Overall, the bill’s framing indicates likely support for addressing fentanyl harms, though the record provided does not show formal debate.
Contention
The main policy issue is the scope of criminal liability for altering or substituting drugs with fentanyl, especially how broadly the felony could apply to conduct involving controlled substances and packaging. Another potential point of concern is ensuring the exemption for medical and pharmacy professionals is clear enough to avoid unintended liability for legitimate handling of medications. No specific opposing arguments, committee objections, or vote-based divisions are included in the provided record.